Skip to main content
Premium Trial:

Request an Annual Quote

Vermillion to Raise $20.5M in Stock Sale Three Months After Disclosing Cash Drought

NEW YORK (GenomeWeb News) — Vermillion, formerly known as Ciphergen Biosystems, today said it plans to gross around $20.5 million in a private stock placement to a group of existing and new investors.
 
Vermillion said it plans to use the net proceeds from the transaction for general working capital needs.
 
The investment, expected to close around Aug. 29, would come three months after Vermillion, then still known as Ciphergen, said in a US Securities and Exchange Commission filing that its current cash balances “may not be sufficient to fund planned expenditures."
  
"This raises substantial doubt about our ability to continue as a going concern," the company said at the time. 
 
Under the terms of the private placement announced today, Vermillion will sell approximately 24.4 million shares of its common stock and issue warrants for around 19.5 million additional shares with an exercise price of $0.925 per share, the company said.
 
Earlier this week, the company changed its name to Vermillion and said it expects to begin trading on the Nasdaq exchange Aug. 27 under the ticker symbol VRML.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.